Allen Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$713K Sell
1,969
-375
-16% -$128K 0.35% 36
2026
Q1
$825K Sell
2,344
-124
-5% -$44.2K 0.41% 35
2025
Q4
$808K Sell
2,468
-10
-0.4% -$3.17K 0.49% 36
2025
Q3
$699K Sell
2,478
-261
-10% -$75.7K 0.47% 34
2025
Q2
$765K Sell
2,739
-20
-0.7% -$5.67K 0.53% 33
2025
Q1
$860K Hold
2,759
0.59% 32
2024
Q4
$719K Sell
2,759
-69
-2% -$20.5K 0.52% 35
2024
Q3
$911K Sell
2,828
-50
-2% -$16.4K 0.63% 31
2024
Q2
$899K Buy
2,878
+59
+2% +$17.3K 0.8% 30
2024
Q1
$801K Sell
2,819
-50
-2% -$14.6K 0.71% 34
2023
Q4
$826K Buy
+2,869
New +$782K 0.81% 31

Other funds holding AMGN

Allen Wealth Management's AMGN Position: Q2 2026 in Review

Allen Wealth Management reduced its Amgen (AMGN) stake by 16% in Q2 2026, selling an estimated $128K and leaving 1,969 shares worth $713K. The position accounts for 0.35% of the portfolio, ranked #36.

Allen Wealth Management first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $911K in Q3 2024. 1,456 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Allen Wealth Management held 1,969 shares of Amgen worth $713K as of Q2 2026.
  • Allen Wealth Management sold 375 Amgen shares in Q2 2026, an estimated $128K.
  • Amgen made up 0.35% of Allen Wealth Management's portfolio in Q2 2026, its #36 holding.
  • Allen Wealth Management first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
  • Allen Wealth Management's Amgen position peaked at $911K in Q3 2024.
  • 1,456 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Allen Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.